MKC Stock Analysis: McCormick | NYSE
Packaged Foods | NYSE, USA | Market Cap: 13.432m USD | 12M Return: -27.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 188M
EPS Trend: 90.7%
Qual. Beats: 2
Rev. Trend: 81.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
McCormick & Company, Incorporated (NYSE: MKC) manufactures, markets, and distributes herbs, spices, seasoning mixes, condiments, and other flavor products for the global food industry. The company operates through two business segments: Consumer, which sells branded retail products across the Americas, EMEA, and Asia/Pacific under labels such as McCormick, Frenchs, Franks RedHot, Lawrys, Cholula, OLD BAY, Ducros, and Schwartz; and Flavor Solutions, which supplies seasoning blends, spices, condiments, coating systems, and compound flavors to multinational food manufacturers and foodservice operators. Founded in 1889 and headquartered in Hunt Valley, Maryland, McCormick runs a dual B2C/B2B model in which branded consumer sales drive retail scale while the Flavor Solutions segment anchors ingredient relationships with industrial and foodservice customers.
As a large-cap member of the Consumer Staples sector within the Packaged Foods & Meats sub-industry, McCormick benefits from defensive, relatively non-cyclical demand, as spice and seasoning consumption tends to remain stable through economic downturns. Its portfolio of category-leading brands and broad geographic reach support pricing power and shelf-space advantages in grocery, mass merchandise, warehouse clubs, and e-commerce channels, complementing its private-label and ingredient supply businesses.
- Flavor Solutions segment growth driven by foodservice demand recovery
- Consumer branded pricing offsets soft volume in retail channel
- Cholula and Frenchs acquisitions expand condiment category share
| Net Income: 1.63b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.84 > 1.0 |
| NWC/Revenue: -10.60% < 20% (prev -15.12%; Δ 4.52% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.23b > Net Income 1.63b |
| Net Debt (4.77b) to EBITDA (1.39b): 3.43 < 3 |
| Current Ratio: 0.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (269.2m) vs 12m ago -0.07% < -2% |
| Gross Margin: 38.62% > 18% (prev 38.54%; Δ 0.08% > 0.5%) |
| Asset Turnover: 49.79% > 50% (prev 51.12%; Δ -1.33% > 0%) |
| Interest Coverage Ratio: 5.48 > 6 (EBIT TTM 1.13b / Interest Expense TTM 206.7m) |
| A: -0.05 (Total Current Assets 2.79b - Total Current Liabilities 3.57b) / Total Assets 16.5b |
| B: 0.29 (Retained Earnings 4.84b / Total Assets 16.5b) |
| C: 0.08 (EBIT TTM 1.13b / Avg Total Assets 14.8b) |
| D: 0.79 (Book Value of Equity 7.00b / Total Liabilities 8.90b) |
| Altman-Z'' = 1.98 = BBB |
| DSRI: 1.11 (Receivables 709.4m/584.5m, Revenue 7.39b/6.74b) |
| GMI: 1.00 (GM 38.54% / 38.62%) |
| AQI: 1.02 (AQ_t 0.74 / AQ_t-1 0.73) |
| SGI: 1.10 (Revenue 7.39b / 6.74b) |
| TATA: 0.02 (NI 1.63b - CFO 1.23b) / TA 16.5b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of July 28, 2026, the stock is trading at USD 50.61 with a total of 3,394,807 shares traded. Over the past week, the price has changed by -3.12%, over one month by -1.90%, over three months by +1.33% and over the past year by -27.05%.
Current recommended Stop Loss: 48.10 (which is 5% or 1.5 ATR below the current price).
McCormick has received a consensus analysts rating of 3.44. Therefore, it is recommended to hold MKC.
- StrongBuy: 4
- Buy: 1
- Hold: 9
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 60.6 | 19.8% |
P/E Trailing = 8.3128
P/E Forward = 16.1812
P/S = 1.8186
P/B = 1.92
P/EG = 2.1558
Revenue TTM = 7.39b USD
EBIT TTM = 1.13b USD
EBITDA TTM = 1.39b USD
Long Term Debt = 3.60b USD (from longTermDebt, last quarter)
Short Term Debt = 1.34b USD (from shortTermDebt, last quarter)
Debt = 5.10b USD (from shortLongTermDebtTotal, last quarter) + Leases 167.7m
Net Debt = 4.77b USD (calculated: Debt 5.10b - CCE 331.2m)
Enterprise Value = 18.2b USD (13.4b + Debt 5.10b - CCE 331.2m)
Interest Coverage Ratio = 5.48 (Ebit TTM 1.13b / Interest Expense TTM 206.7m)
EV/FCF = 15.72x (Enterprise Value 18.2b / FCF TTM 1.16b)
FCF Yield = 6.36% (FCF TTM 1.16b / Enterprise Value 18.2b)
FCF Margin = 15.68% (FCF TTM 1.16b / Revenue TTM 7.39b)
Net Margin = 22.05% (Net Income TTM 1.63b / Revenue TTM 7.39b)
Gross Margin = 38.62% ((Revenue TTM 7.39b - Cost of Revenue TTM 4.53b) / Revenue TTM)
Gross Margin QoQ = 40.18% (prev 37.83%)
Tobins Q-Ratio = 1.10 (Enterprise Value 18.2b / Total Assets 16.5b)
Interest Expense / Debt = 4.05% (Interest Expense 206.7m / Debt 5.10b)
Taxrate = 22.56% (217.1m / 962.2m)
NOPAT = 877.5m (EBIT 1.13b * (1 - 22.56%))
Current Ratio = 0.78 (Total Current Assets 2.79b / Total Current Liabilities 3.57b)
Debt / Equity = 0.73 (Debt 5.10b / totalStockholderEquity, last quarter 7.00b)
Debt / EBITDA = 3.43 (Net Debt 4.77b / EBITDA 1.39b)
Debt / FCF = 4.12 (Net Debt 4.77b / FCF TTM 1.16b)
Total Stockholder Equity = 6.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.98% (Net Income 1.63b / Total Assets 16.5b)
RoE = 25.58% (Net Income TTM 1.63b / Total Stockholder Equity 6.37b)
RoCE = 11.37% (EBIT 1.13b / Capital Employed (Equity 6.37b + L.T.Debt 3.60b))
RoIC = 6.31% (NOPAT 877.5m / Invested Capital 13.9b)
WACC = 5.34% (E(13.4b)/V(18.5b) * Re(6.18%) + D(5.10b)/V(18.5b) * Rd(4.05%) * (1-Tc(0.23)))
Discount Rate = 6.18% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.13 | Cagr: -0.07%
[DCF] Terminal Value 77.97% ; FCFF base≈915.5m ; Y1≈1.05b ; Y5≈1.54b
[DCF] Fair Price = 72.71 (EV 23.2b - Net Debt 4.77b = Equity 18.5b / Shares 254.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.71 | EPS CAGR: 6.12% | SUE: 1.77 | # QB: 2
Revenue Correlation: 81.35 | Revenue CAGR: 2.93% | SUE: 0.80 | # QB: 0
EPS current Quarter (2026-08-31): EPS=0.76 | Chg30d=-9.69% | Revisions=-77% | Analysts=11
EPS current Year (2026-11-30): EPS=3.09 | Chg30d=-0.16% | Revisions=-58% | GrowthEPS=+2.9% | GrowthRev=+15.4%
EPS next Year (2027-11-30): EPS=3.30 | Chg30d=-1.07% | Revisions=-58% | GrowthEPS=+6.8% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: -77% (up=2, down=26)